Anzeige
Mehr »
Login
Donnerstag, 23.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Mit dieser Aktie könntest Du von der Cannabis-Legalisierungswelle profitieren!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3D37R | ISIN: US47010C7065 | Ticker-Symbol: 1JAA
Tradegate
22.05.24
21:58 Uhr
0,121 Euro
+0,003
+2,20 %
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
JAGUAR HEALTH INC Chart 1 Jahr
5-Tage-Chart
JAGUAR HEALTH INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,1180,12022.05.
0,0000,00022.05.

Aktuelle News zur JAGUAR HEALTH Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiXFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 22.05.2024304The following instruments on Boerse Frankfurt do have their last trading day on 22.05.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 22.05.2024ISIN NameCA00971M2058 AKANDA...
► Artikel lesen
MiXFRA ISIN CHANGE239Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenUS47010C7065 Jaguar Health Inc. 22.05.2024 US47010C8055 Jaguar Health Inc. 23.05.2024 Tausch 60:1 CA1089093001 Pace...
► Artikel lesen
MiXFRA CAPITAL ADJUSTMENT INFORMATION - 22.05.2024234Das Instrument A07 BMG067231032 AVANCE GAS HLDG DL 2 EQUITY wird cum Kapitalmassnahme gehandelt am 22.05.2024 und ex Kapitalmassnahme am 23.05.2024 The instrument A07 BMG067231032 AVANCE GAS HLDG DL...
► Artikel lesen
MoWhy Jaguar Health Stock Is Tanking53
MoWhy Is Jaguar Health (JAGX) Stock Down 40% Today?33
FrJaguar Health announces reverse stock split66
FrJaguar Health, Inc. Announces Reverse Stock Split475Reverse split approved at April 2024 Special Meeting of StockholdersShares of Jaguar Health common stock to begin trading on split-adjusted basis on May 23, 2024 SAN FRANCISCO, CA / ACCESSWIRE / May...
► Artikel lesen
14.05.Earnings call: Jaguar Health reports Q1 2024 revenue increase29
14.05.Jaguar Health Inc reports results for the quarter ended in March - Earnings Summary24
14.05.Jaguar Health, Inc.: Jaguar Health Reports First Quarter 2024 Financial Results385The combined net Q1 2024 revenue of approximately $2.4 million for prescription and non-prescription products increased approximately 20% versus net Q1 2023 revenue of $2.0 million and increased approximately...
► Artikel lesen
14.05.Jaguar Health, Inc. - 10-Q, Quarterly Report37
13.05.Jaguar Health, Inc.: REMINDER: Jaguar Health to Hold Investor Webcast Tuesday, May 14th at 8:30 AM Eastern Regarding Q1 2024 Financials & Corporate Updates318Click here to register for May 14 investor webcastCompany plans to file its Earnings Report on May 14, 2024 on Form 10-Q for the quarter ended March 31, 2024 SAN FRANCISCO, CA / ACCESSWIRE / May 13...
► Artikel lesen
13.05.Jaguar Health Q1 2024 Earnings Preview18
09.05.Peering Into Jaguar Health's Recent Short Interest36
09.05.Jaguar Health, Inc.: Jaguar Health Announces Submission of Clinical Trial Applications for Crofelemer for the Rare Disease Indications Microvillus Inclusion Disease and Short Bowel Syndrome in Europe436Jaguar's novel plant-based prescription drug crofelemer has been granted Orphan Drug Designation by the FDA and the European Medicines Agency for both MVID and SBS SAN FRANCISCO, CA / ACCESSWIRE / May...
► Artikel lesen
08.05.Jaguar Health, Inc.: Jaguar Health to Hold Investor Webcast Tuesday, May 14th at 8:30 AM Eastern Regarding Q1 2024 Financials & Corporate Updates319Click here to register for May 14 investor webcastCompany plans to file its Earnings Report on May 14, 2024 on Form 10-Q for the quarter ended March 31, 2024 SAN FRANCISCO, CA / ACCESSWIRE / May 8,...
► Artikel lesen
06.05.Jaguar Health, Inc.: Crofelemer, Jaguar Health's Prescription Drug Conditionally Approved by the FDA for Chemotherapy-Induced Diarrhea in Dogs, is the Subject of the Company's Investigational New Animal Drug Application for the Indication of General Diarr404Diarrhea is one of the most common reasons for veterinary visits for dogs and the second most common reason for visits to the veterinary emergency room, yet there are currently no FDA-approved anti-secretory...
► Artikel lesen
02.05.JAGX, SNSE and BON among mid-day movers163
29.04.Jaguar Health, Inc.: Napo Pharmaceuticals, a Jaguar Health Family Company, Sponsoring Pediatric Gastroenterology Conference in Abu Dhabi and Panel Discussion About Microvillus Inclusion Disease703Jaguar's novel plant-based prescription drug crofelemer has been granted Orphan Drug Designation by the FDA and the European Medicines Agency for both MVID and short bowel syndrome (SBS) with intestinal...
► Artikel lesen
22.04.Jaguar Health, Inc.: Napo Pharmaceuticals, a Jaguar Health Family Company, to Exhibit at Oncology Nursing Society Congress in Support of Company's Expanding Focus on Cancer Supportive Care501Jaguar planning to begin commercial launch of FDA-approved Gelclair® prescription gel for oral mucositis (also called "chemo mouth") in Q3 2024Company to feature "Make Cancer Less Shitty" patient advocacy...
► Artikel lesen
Seite:  Weiter >>
115 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
4,6,45